The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
Abstract Soft‐tissue sarcomas (STS) represent a group of rare and heterogeneous tumors associated with several challenges, including incorrect or late diagnosis, the lack of clinical expertise, and limited therapeutic options. Digital pathology and radiomics represent transformative technologies tha...
Main Authors: | Amandine Crombé, Mathtieu Roulleau‐Dugage, Antoine Italiano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Cancer Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/cac2.12373 |
Similar Items
-
Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
by: Matthieu Roulleaux Dugage, et al.
Published: (2021-12-01) -
Editorial: Precision medicine in sarcomas: the road to an effective biomarker-driven-care strategy
by: Samia Arifi, et al.
Published: (2023-04-01) -
Sarcoma Immunotherapy
by: R. Lor Randall, et al.
Published: (2011-11-01) -
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma
by: Arash O. Naghavi, et al.
Published: (2024-04-01) -
Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
by: William G. J. Kerrison, et al.
Published: (2022-02-01)